From: Pancreatic stone protein point-of-care testing can reduce healthcare expenditure in sepsis
Parameter | Standard of Care | Rapid PSP | Source |
---|---|---|---|
Base Parameters | |||
Length of stay on the regular ward (days; TP)a | 6.5 | ||
Length of stay in the ICU (days; TP)a | 10.6 | ||
Antibiotic days of therapy | 19.0 | ||
Emergency Department | |||
Incidence of sepsis among patients presenting with infection | 41% | Rhee 2017 [3] | |
30-day readmission for infection | 20% | Broyles 2017 [30] | |
Patients admitted to the ICU | 8% | Broyles 2017 [30] | |
Intensive Care Unit | |||
Incidence of sepsis among patients | 77% | ||
30-day readmission for infection | 28% | Bishop 2014 [33] | |
Sensitivity & Specificity | |||
Test sensitivity | 34% | 85% | PSP: Average of Llewelyn 2013, Garcia de Guadiana-Romualdo 2017 [21, 28]; SOC: Singer 2014 [34] |
Test specificity | 82% | 80% | PSP: Average of Llewelyn 2013, Garcia de Guadiana-Romualdo 2017 [21, 28]; SOC: Singer 2014 [34] |
Antibiotic Resistance (ABR) | |||
Prevalence of ABR | 19.40% | Burnham 2015 [9] | |
Percent Reduction in ABR per percent reduced antibiotic days | 3.20% | Mewes 2019 [23] | |
Additional length of stay due to ABRa | 4.6 | ||
Clostridium difficile infection (CDI) | |||
Prevalence of CDI | 3% | Mewes 2019 [23] | |
Additional length of stay due to CDI | 5.85 |